| Authors: |
Russell NH; Nigel H. Russell, MD, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom; Abin Thomas, PhD, Centre for Trials Research, Cardiff University, Cardiff, United Kingdom; and Sylvie D. Freeman, MB ChB, DPhil, School of Infection, Inflammation and Immunology, University of Birmingham College of Medicine and Health, Birmingham, United Kingdom., Thomas A; Nigel H. Russell, MD, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom; Abin Thomas, PhD, Centre for Trials Research, Cardiff University, Cardiff, United Kingdom; and Sylvie D. Freeman, MB ChB, DPhil, School of Infection, Inflammation and Immunology, University of Birmingham College of Medicine and Health, Birmingham, United Kingdom., Freeman SD; Nigel H. Russell, MD, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom; Abin Thomas, PhD, Centre for Trials Research, Cardiff University, Cardiff, United Kingdom; and Sylvie D. Freeman, MB ChB, DPhil, School of Infection, Inflammation and Immunology, University of Birmingham College of Medicine and Health, Birmingham, United Kingdom. |